- Home
- EVOK vs SDSTW Comparison
EVOK vs SDSTW Comparison
Compare EVOK & SDSTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVOK | SDSTW |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | 8 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4M | 3.4M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | EVOK | SDSTW |
|---|---|---|
| Price | $10.97 | $0.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.4K | ★ 41.6K |
| Earning Date | 11-13-2025 | 03-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,424,652.00 | N/A |
| Revenue This Year | $58.96 | N/A |
| Revenue Next Year | $57.99 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 67.40 | N/A |
| 52 Week Low | $1.94 | $0.10 |
| 52 Week High | $10.99 | $0.12 |
Technical Indicators
Market Signals| Indicator | EVOK | SDSTW |
|---|---|---|
| Relative Strength Index (RSI) | 84.66 | 41.17 |
| Support Level | $10.66 | $0.11 |
| Resistance Level | $10.75 | $0.17 |
| Average True Range (ATR) | 0.05 | 0.01 |
| MACD | -0.19 | -0.00 |
| Stochastic Oscillator | 87.50 | 22.37 |
Price Performance
Historical ComparisonAbout EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About SDSTW Stardust Power Inc. Warrant
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).